Immortal time bias in observational analyses of linezolid interruption and rechallenge
Authors:
Open Access
- 3 June 2026
- journal article
- Published by Elsevier in The Lancet Global Health
- Vol. 14 (7) , 103978
Abstract
No abstract availableFunding Information
- National Institute of Allergy and Infectious Diseases
This publication has 4 references indexed in Scilit:
- Association of linezolid interruption and rechallenge with clinical outcomes in patients with rifampicin-resistant tuberculosis in South Africa, 2018–22: an observational cohort studyThe Lancet Global Health, 2026
- The Target Trial Framework for Causal Inference From Observational Data: Why and When Is It Helpful?Annals of Internal Medicine, 2025
- A Structural Description of Biases That Generate Immortal TimeEpidemiology, 2024
- Effectiveness of Bedaquiline Use beyond Six Months in Patients with Multidrug-Resistant TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2023